title: Viral infections in patients with inflammatory bowel disease on immunosuppressants.
abstract: The use of immunosuppressant medications and biologics such as tumor necrosis factor alpha antagonists has revolutionized the treatment of inflammatory bowel disease. With increasing use of such agents, the risk of serious infections is a key safety concern for treated patients. Greater physician awareness about these potential infections is important to optimize patient outcomes through early recognition and potential preventive strategies. The authors present a comprehensive and concise review of clinically important viral infections associated with the inflammatory bowel disease therapy.
authors.affiliation: Section of Gastroenterology, University of Oklahoma Health Sciences Center, Oklahoma City, USA. Tauseef-ali@ouhsc.edu
authors.forename: Tauseef
authors.initials: T
authors.lastname: Ali
authors.forename: Laura
authors.initials: L
authors.lastname: Yun
authors.forename: David
authors.initials: D
authors.lastname: Shapiro
authors.forename: Mohammad F
authors.initials: MF
authors.lastname: Madhoun
authors.forename: Michael
authors.initials: M
authors.lastname: Bronze
mesh_terms: D003586:Cytomegalovirus Infections / Q000209:etiology; D020031:Epstein-Barr Virus Infections / Q000209:etiology; D006509:Hepatitis B / Q000209:etiology; D006561:Herpes Simplex / Q000209:etiology; D006562:Herpes Zoster / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology; D030361:Papillomavirus Infections / Q000209:etiology; D014777:Virus Diseases / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents